These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3191519)

  • 1. Retardation of the development of hypertension in DOCA salt rats by taurine supplement.
    Inoue A; Takahashi H; Lee LC; Sasaki S; Kohno Y; Takeda K; Yoshimura M; Nakagawa M
    Cardiovasc Res; 1988 May; 22(5):351-8. PubMed ID: 3191519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The antihypertensive effect of taurine in DOCA-salt rats.
    Fujita T; Sato Y
    J Hypertens Suppl; 1984 Dec; 2(3):S563-5. PubMed ID: 6152784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypotensive responses to centrally administered taurine in DOCA-salt hypertensive and spontaneously hypertensive rats.
    Inoue A; Takahashi H; Lee LC; Sasaki S; Takeda K; Yoshimura M; Nakagawa M; Ijichi H
    Jpn Circ J; 1986 Dec; 50(12):1215-23. PubMed ID: 3820530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the renal nerves in the maintenance of DOCA-salt hypertension in the rat. Influence on the renal vasculature and sodium excretion.
    Katholi RE; Naftilan AJ; Bishop SP; Oparil S
    Hypertension; 1983; 5(4):427-35. PubMed ID: 6345357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of sympathetic nervous system in hypotensive action of taurine in DOCA-salt rats.
    Sato Y; Ando K; Fujita T
    Hypertension; 1987 Jan; 9(1):81-7. PubMed ID: 2878880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypotensive effect of taurine. Possible involvement of the sympathetic nervous system and endogenous opiates.
    Fujita T; Sato Y
    J Clin Invest; 1988 Sep; 82(3):993-7. PubMed ID: 2971083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in renal and central noradrenergic activity with potassium in DOCA-salt rats.
    Fujita T; Sato Y
    Am J Physiol; 1984 May; 246(5 Pt 2):F670-5. PubMed ID: 6144278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypotensive action of taurine in DOCA-salt rats--involvement of sympathoadrenal inhibition and endogenous opiate.
    Sato Y; Ogata E; Fujita T
    Jpn Circ J; 1991 May; 55(5):500-8. PubMed ID: 2062001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in cardiac and hypothalamic noradrenergic activity with taurine in DOCA-salt rats.
    Fujita T; Sato Y; Ando K
    Am J Physiol; 1986 Nov; 251(5 Pt 2):H926-33. PubMed ID: 2877584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retardation of the development of hypertension in DOCA-salt rats by renal denervation.
    Takahashi H; Iyoda I; Yamasaki H; Takeda K; Okajima H; Sasaki S; Yoshimura M; Nakagawa M; Ijichi H
    Jpn Circ J; 1984 Jun; 48(6):567-74. PubMed ID: 6547490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of renal sympathetic activity with potassium supplement in DOCA-salt rats.
    Sato Y; Fujita T
    Jpn Heart J; 1984 Mar; 25(2):253-61. PubMed ID: 6748225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of norepinephrine release from vascular adrenergic neurons by oral administration of beta-blocker in DOCA-salt hypertension.
    Tsuda K; Masuyama Y
    Am J Hypertens; 1991 Jan; 4(1 Pt 1):68-71. PubMed ID: 2007000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Importance of renal sympathetic tone in the development of DOCA-salt hypertension in the rat.
    Katholi RE; Naftilan AJ; Oparil S
    Hypertension; 1980; 2(3):266-73. PubMed ID: 6993358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paraventricular nucleus lesions attenuate the development of hypertension in DOCA/salt-treated rats.
    Nakata T; Takeda K; Itho H; Hirata M; Kawasaki S; Hayashi J; Oguro M; Sasaki S; Nakagawa M
    Am J Hypertens; 1989 Aug; 2(8):625-30. PubMed ID: 2570597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A comparative study of C19 steroid-induced hypertension and deoxycorticosterone acetate (DOCA)-salt hypertension].
    Minato M; Honda M; Hatano M
    Nihon Naibunpi Gakkai Zasshi; 1990 Jan; 66(1):29-41. PubMed ID: 2307256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in blood pressure and extracellular fluid with taurine in DOCA-salt rats.
    Fujita T; Sato Y
    Am J Physiol; 1986 Jun; 250(6 Pt 2):R1014-20. PubMed ID: 3717374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attenuated development of hypertension by chronic administration of bromocriptine in Doca-salt hypertensive rats.
    Kambara S; Yoshimura M; Okabayashi H; Takahashi H; Ijichi H
    Jpn Circ J; 1986 Nov; 50(11):1120-7. PubMed ID: 3102804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of sympathetic nerve activity and natriuresis in the antihypertensive actions of potassium in NaCl hypertension.
    Fujita T; Sato Y; Ando K
    Jpn Circ J; 1983 Oct; 47(10):1227-31. PubMed ID: 6632175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antihypertensive action of K in rats with DOCA-salt-induced hypertension].
    Sato Y; Fujita T; Yamashita K
    Nihon Yakurigaku Zasshi; 1983 Aug; 82(2):117-30. PubMed ID: 6662415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasopressin and sympathetic nervous functions both contribute to development and maintenance of hypertension in DOCA-salt rats.
    Takata Y; Yamashita Y; Takishita S; Fujishima M
    Clin Exp Hypertens A; 1988; 10(2):203-27. PubMed ID: 3370846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.